Coccidioidomycosis (Valley Fever)

Coccidioidomycosis (Valley Fever)

Coccidioidomycosis (Valley Fever) is a benign fungal disease affecting cattle and dogs. It creates a major public health problems in human.

Coccidioidomycosis (Valley Fever) is a non contagious infection.

Etiology

  • Coccidioides immitis cause Coccidioidomycosis (Valley Fever).
  • C. immitis is a dimorphic, saprophytic organism develops as a mycelium in the soil and produces a spherules within the host.
  • Arthroconidia (arthrospores) produced by the hyphae are the infectious units of the organism.
  • The spores are known as arthroconidia (Barrel shaped).
  • C. immitis colonies grow rapidly. It produce white, cottony colonies and in old culture it turn to tan to brown color.
  • It is dormant during long dry period and develops as a mold with long filaments that break off into airborne spores following rainfall.

Epidemiology

Prevalence of infection

  • It is enzootic in South West US and up to 20% of cattle reared under feed lot condition.
  • It is a fungal disease and is sporadic in distribution.
  • Coccidioides spp. is endemic in hot and semi-arid zones.
  • The organism is detected in humans or animals present in endemic areas.

Predisposing factors

  • Coccidioides spp. grows in the soil as mycelia with lateral growing “barrel” shaped arthroconidia.
  • Coccidioides lies dormant in the mycelial phase during the times of draught, but heavy rain causes germination of the arthroconidia and production of more mycelia.
  • Infection occurs most often during dry weather disperse the conidia more easily following periods of heavy rain and wind.
  • Soil also promote exposure.

Transmission

  • The disease spread by means of inhalation of spores which are saprophytic in nature.
  • Infection may also occur through cutaneous abrasions.
  • The disease is not transmitted from person to person.

Host affected

  • Cattle, deer, dogs, elk, fish, mules, apes, kangaroos, wallabies, tigers, bears, badgers, otters and marine mammals are affected.
  • The disease also affects lesser extent the species such as pigs, sheep and horses.
  • Pulmonary coccidioidomycosis recorded in adult foal.
  • Human beings are affected.

Pathogenesis

  • Following inhalation of the arthroconidia, few conidia can produce infection.
  • Arthroconidia are distributed through the alveoli phagocytosed and develops to spherules, which then enlarge and undergo endosporulation.
  • The spherules rupture and release endospores into surrounding tissues, and spread locally or disseminate hematogenously to extra pulmonary sites.
  • The endospores develop into spherules and continue the cycle until host develop resistance.
  • Reactivation of latent infection is thought to occur in immunosuppressed patients.
  • T lymphocytes recognizing coccidioides antigens in the first four to six weeks of infection and activate macrophages to halt progression of infection.
  • In humans, those with impaired cell mediated immunity suffer from severe form of progressive coccidioidomycosis.
  • If conidia inhaled, they produce spherules, thus propagating the infection.
  • The hematogenous spread of the pathogen in the host’s bloodstream results in infection of skin, bones, joints, lymph nodes, adrenal glands and central nervous system.
  • Once the arthroconidia are inhaled, the fungus develops into 30-60 micron diameter spherules that are filled with 3-5 micron diameter endospores.
  • The large spherules then release the endospores that continue the infection.

Clinical Signs

  • Weight loss, severe emaciation, fluctuation of body temperature, persistent cough, muscle pain, superficial abscesses with frequent recurrence.
  • Muscle pain and development of superficial abscess in pectoral area is most common.
  • Increased lung sounds, wheezing, dullness are audible over the vertical chest area.
  • Other signs includes edema of legs, anaemia, intermittent colic due to internal abscesses and peritoneal adhesions.
  • Death due to rupture of liver occurs.

Necropsy Findings

  • Cattle and pigs develops granulomatous lesion which contains a creamy coloured pus, calcified materials in bronchial, mediastinal, rarely in mesentric, pharyngeal, submaxillary and supramammary lymphnodes.
  • Lungs of neonatal foal contains diffusely infiltrated miliary pattern of multiple, coalescing, pale tan to red irregular shaped slightly raised firm foci 0.1-0.5 cm in diameter.

Diagnosis

  • Based on clinical signs and necropsy findings.
  • Isolation and identification of organism.
  • An extract of fungal antigen, coccidioidin used in an intradermal sensitivity test.
  • CFT and  Immuno diffusion test in humans.

Differential Diagnosis

  • TB
  • Caseous lymphadenitis

Treatment

  • Oral antifungal agents such as ketoconazole, itraconazole, and fluconazole are given.
  • The role of newer agents, such as voriconazole, posaconazole and caspofungin are still being tried.
  • It is often a self-limiting chronic respiratory or multisystemic disease and it requires a long term antifungal therapy.
  • For disseminated infection, treatment of at least 6-12 months is required.
  • Ketoconazole (10-30 mg/kg/day) or itraconazole (10 mg/kg/day) is commonly used to treat dogs.
  • Amphotericin-B may be used in animals not responding to azole antifungals.
  • Fluconazole also be effective. The use of long term fluconazole (2-3 mg/kg/day) resulted in a 55% success rate in monkeys with coccidioidomycosis.
  • Coccidioidomycotic osteomyelitis in a horse has been successfully treated with itraconazole 2.6 mg/kg body weight twice a day for 6 months.

Prevention

  • Dust control is a major factor in prevention of human coccidioidomycosis.
  • No vaccine is available.
  • Infection occurs by inhalation of soil borne spores.
  • Control of dust in feed lots may help to prevent the spread.

Control

  • Eradication of spores from soil is not feasible.
  • Halogens (such as iodine, and chlorine in the form of hypochlorite [bleach]), phenolics and quaternary ammonium compounds are proven effective against Coccidioides spp.
  • Arthroconidia are resistant to dry heat, but they can be inactivated by moist heat (121°C for a minimum of 15 minutes).
Scroll to Top